The US Food And Drug Administration (FDA) has recently approved Glyxambi® (empagliflozin/linagliptin) tablets by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company as a supplement to exercise and diet to improve glycemic control ... Read more